BCAX stock news
This page provides real-time market news, earnings updates, and company announcements related to Bicara Therapeutics Inc. (BCAX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-01 19:00 EST
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
Bicara Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-23 13:34:28
Bicara Therapeutics has officially set the public offering price for its $150 million common stock and pre-funded warrants.
老虎证券2026-02-25 04:42:28
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Finviz2026-02-26 21:03:45
BCAX stock chart
BCAX stock detailsBCAX stock price change
On the last trading day, BCAX stock closed at 16.78 USD, with a price change of -0.12% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more